Comprehensive mutation screening in a cystic fibrosis center

Pediatrics

Volumn 107, Issue 2, 2001, Pages 280-286

  Wine, Jeffrey J ^a   Kuo, Eugene ^a   Hurlock, Gregory ^a   Moss, Richard B ^b  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alleles; CFTR; Heteroduplex analysis; SSCP

Indexed keywords

ALLELE; ARTICLE; COST EFFECTIVENESS ANALYSIS; CYSTIC FIBROSIS; FRAMESHIFT MUTATION; GENE DELETION; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NONSENSE MUTATION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SWEAT TEST;

CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DNA MUTATIONAL ANALYSIS; EXONS; GENETIC SCREENING; HETERODUPLEX ANALYSIS; HUMANS; MUTATION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; SENSITIVITY AND SPECIFICITY;

EID: 0035143990     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.107.2.280     Document Type: Article

References (29)

1. Two novel mutations in a cystic fibrosis patient of Chinese origin
2. Identification of the cystic fibrosis gene: Chromosome walking and jumping
3. Identification of the cystic fibrosis gene: Cloning and characterization of complementary DNA
4. Identification of the cystic fibrosis gene: Genetic analysis
5. Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms
6. Genomic DNA sequence of Rhesus (M. mulatta) cystic fibrosis (CFTR) gene
7. Sensitivity of single-strand conformation polymorphism and heteroduplex method for mutation detection in the cystic fibrosis gene
8. Single-stranded conformation polymorphism analysis of the CFTR gene in Slovenian cystic fibrosis patients: Detection of mutations and sequence variations
9. Identification of 12 novel mutations in the CFTR gene [published erratum appears in Hum Mol Genet 1993 Apr;2(4):496]
10. Sensitivity of the denaturing gradient gel electrophoresis technique in detection of known mutations and novel Asian mutations in the CFTR gene
11. Characterization of more than 85% of cystic fibrosis alleles in the Greek population, including five novel mutations
12. Mutation characterization of CFTR gene in. Northern Irish CF families: Thirty mutations, including two novel, account for approximately 94% of CF chromosomes
13. Distribution of CFTR mutations in cystic fibrosis patients of Tunisian origin: Identification of two novel mutations
14. CFTR gene analysis in cystic fibrosis patients: Detection of 91% of molecular defects and identification of the novel mutation D979V
15. Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis: Y569D, Q98X, 296+12(T>C), 1161delC and 621+2(T>C)
16. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations
17. A novel donor splice site in intron 11 of the CFTR gene, created by mutation 1811+l.6kbA->G, produces a new exon: High frequency in Spanish cystic fibrosis chromosomes and association with severe phenotype
18. Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation
19. Complete mutational screening of the CFTR gene in 120 patients with pulmonary disease
20. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis
21. Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line
22. Aminoglycoside antibiotics restore CFTR function by overcoming premature stop mutations [see comments]
23. Defective function of the cystic fibrosis-causing mutation G551D is recovered by genistein
24. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis
25. Biosynthesis and degradation of CFTR
26. Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive
27. Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation
28. Strategies for correcting the delta F508 CFTR protein-folding defect
29. A pilot clinical trial of oral sodium 4-phenylbutyrate (Buphenyl) in deltaF508-homozygous cystic fibrosis patients: Partial restoration of nasal epithelial CFTR function